GSTM1 and anemia (phenotype): In patients with CHF and ID, IVIS (ferric carboxymaltose) was found to be beneficial for both patients with and without anemia and led to significant improvements in Hb levels, the distance on the 6-min walk test, and quality-of-life assessments (Anker et al. 2009b).